Skip to content
Lower risk Drug recall · FDA · Published May 6, 2022

Sun Pharmaceutical Recalls Medroxyprogesterone Acetate Injectable Due to Sterility Risk

Sun Pharmaceutical recalls 150 mg/mL medroxyprogesterone acetate injectable syringes (NDC 16714-999-01) due to lack of sterility assurance. Affected lots expired between June 2022 and June 2023. Contact for details.

🇺🇸 FDA recall #D-1144-2022DrugSun Pharmaceutical ›
Take action

Contact the company

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way · Princeton, NJ 08540-6620
✎ GovInfoNow plain-language explainer

Sun Pharmaceutical is recalling certain medroxyprogesterone acetate injectable syringes because they may not be sterile. This could lead to infections if used improperly. Patients with prescriptions for this medication should check their product details. Read more at govinfonow.com/recall/34788-sun-pharmaceutical-recalls-medroxyprogesterone-acetate-injectable-due-to-sterility-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/34788-sun-pharmaceutical-recalls-medroxyprogesterone-acetate-injectable-due-to-sterility-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-1144-2022

Cite this page

“Sun Pharmaceutical Recalls Medroxyprogesterone Acetate Injectable Due to Sterility Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34788-sun-pharmaceutical-recalls-medroxyprogesterone-acetate-injectable-due-to-sterility-risk. Based on FDA recall #D-1144-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1144-2022%22&limit=1).

The FDA announced on May 6, 2022, that Sun Pharmaceutical Industries Inc. voluntarily recalled medroxyPROGESTERone Acetate Injectable Suspension due to a lack of assurance of sterility. The recall affects 57,997 syringes distributed nationwide.

How to tell if you have it

  • Brand: Sun Pharmaceutical
  • Product: medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL
  • NDC: 16714-999-01
  • Lot codes: HAC1289A (Exp 06/2023), JKX2679A (Exp 06/2022), JKX3762A (Exp 08/2022), HAC0164A (Exp 06/2023)
  • Quantity: 57,997 syringes

The hazard

The recall was initiated because the firm could not assure sterility of the product. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Sun Pharmaceutical Industries Inc. has 93 other recalls on record since May 21, 2013. Other recent recalls include a September 14, 2026 Nystatin Cream recall for failed stability specifications and an August 3, 2026 Carbamazepine Tablets recall for black spots from burnt ingredients. Similar product recalls in June 2026 involved Reliance Pemetrexed Injection sterility risks and a February 26, 2026 New Life Pharma Semaglutide Injections recall for lack of sterility assurance.

How to tell if you have this one

Check for the product name 'medroxyprogesterone acetate injectable suspension, USP, 1 mL prefilled syringe, 150 mg/mL'. Look for lot numbers HAC1289A, JKX2679A, JKX3762A, or HAC0164A with specific expiration dates.

  • Brand
    Sun Pharmaceutical
  • Category
    Drug
FDA recall event · 5 products

All 5 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    USA Nationwide
Recall numberProduct, codes & lotsQuantityNDC
D-1143-2022medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India Distributed by: Afaxys Pharma, LLC, Charleston, SC, 29403, USA, Product of Italy, NDC 50102-591-40.; Lots#: JKX4312A & JKX4313A, Exp 09/2022; JKX4827A, Exp 09/2023; HAC1290A & HAC2082B, Exp 06/2023;79339 syringes—
D-1144-2022medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 16714-999-01.; Lot#: HAC1289A, Exo 06/2023; JKX2679A, Exp 06/2022; JKX3762A, Exp 08/2022; HAC0164A, Exp 06/2023.57997 syringes—
D-1145-2022medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 62756-091-40.; Lot #: HAC1951A, Exp 06/20234625 syringes62756-091-40
D-1146-2022medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Single-Dose Vial, 150 mg/mL, Rx only, Manufactured for: Northstart Rx LLC, Memphis, TN, 38141, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol Baroda Highway, Halol-389 350, Gujarat India , NDC 16714-981-01.; Lot: HAC2075A, Exp 06/2023; HAC2076A, Exp 07/2023; HAC2077A, HAC2078A, Exp 08/2023; HAC3803A, Exp 09/2023; HAC0551A, Exp 02/2023; HAC0562A, HAC1183A, Exp 03/2023; HAC1807A, Exp 06/2023; JKX6017A, JKX6018A Exp 12/2022; HAC0163A, Exp 01/2023; HAC1184A, Exp 04/2023; HAC0162A, Exp 12/2022.180813 syringes—
D-1147-2022medroxyPROGESTERone Acetate Injectable Suspension, USP, 25 x 1 mL Single-Dose Vial, 150 mg/mL, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol Baroda Highway, Halol-389 350, Gujarat India , NDC 16714-090-40 packaged in 25 count carton.; Lot#: HAC2074A, Exp Date 06/2023; HAC0163B, Exp Date 01/2023 & HAC1741A, Exp Date 04/202326892 vials—
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the lot number and expiration date on the syringe label to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: May 6, 202212. FDA classified it Class II: Jun 10, 202223. Published in FDA’s Enforcement Report: Jun 22, 202234. FDA terminated the recall: Aug 14, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sun Pharmaceutical recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1144-2022 (May 6, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1144-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA